bigram

This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

bigram	frequency
venous thromboembolism	332
design method	318
critically ill	219
united states	193
risk factors	173
pulmonary embolism	173
hospitalized patients	171
ill patients	155
states background	148
care unit	146
bone marrow	141
intensive care	140
patients admitted	135
brain injury	133
coronavirus disease	125
pediatric patients	124
medical patients	120
vte prophylaxis	120
neurocritical care	114
acute respiratory	113
high risk	112
ischemic stroke	111
icu patients	109
mean age	108
sickle cell	103
chart review	99
mg kg	97
dimer levels	92
increased risk	92
patients received	89
status epilepticus	87
novel coronavirus	86
retrospective chart	82
vein thrombosis	81
one patient	81
platelet count	81
subarachnoid hemorrhage	80
cell disease	80
median age	79
stem cell	76
patients receiving	72
cohort study	71
vte risk	70
deep vein	69
severe covid	69
respiratory distress	67
within hours	65
critical care	65
thrombotic complications	64
mechanical ventilation	64
blood cell	62
old female	62
two patients	61
traumatic brain	61
significantly higher	60
respiratory syndrome	60
statistically significant	60
acutely ill	60
case series	59
pediatric oncology	59
intracerebral hemorrhage	59
old male	57
patient population	57
clinical trials	57
mg dl	57
cardiac arrest	57
major bleeding	56
medical center	56
risk assessment	55
patients without	55
thromboembolic events	55
severe acute	55
logistic regression	53
distress syndrome	53
ill medical	53
lymphoblastic leukemia	52
cell lines	52
year old	52
acute lymphoblastic	51
poor outcome	51
bleeding risk	51
clinical characteristics	51
hospital discharge	51
respiratory failure	50
therapeutic anticoagulation	50
retrospective review	50
cerebral edema	50
years old	50
patients treated	49
clinical trial	49
case report	48
sample size	48
coronavirus pneumonia	48
significant difference	48
three patients	47
poor prognosis	47
acute ischemic	47
hospital mortality	47
within days	47
four patients	46
patients undergoing	46
ng ml	46
childhood cancer	46
intracranial hemorrhage	46
among patients	46
venous thrombosis	45
patients hospitalized	45
informed consent	44
hospital admission	44
inclusion criteria	43
intravascular coagulation	43
atrial fibrillation	43
blood pressure	43
emergency department	43
brain death	43
retrospective study	43
disseminated intravascular	42
health care	42
clinical course	42
weight heparin	42
antithrombotic therapy	41
hospitalized covid	41
symptomatic vte	40
medical records	40
blood cultures	40
myocardial infarction	40
rights reserved	40
adult patients	40
anticoagulant thromboprophylaxis	40
intracranial pressure	39
oncology patients	39
retrospective cohort	39
higher risk	39
risk factor	39
least one	39
blood flow	39
quality improvement	38
side effects	38
factor viii	38
red blood	38
study period	38
syndrome coronavirus	37
hematopoietic stem	37
vte patients	37
acute pulmonary	37
ml min	37
adverse events	37
randomized controlled	37
coagulation parameters	36
cord uid	36
hospital stay	36
head ct	36
doc id	36
anticoagulant therapy	35
decision making	35
overall survival	35
medically ill	35
unfractionated heparin	35
clinical practice	35
health system	34
newly diagnosed	34
pediatric cancer	34
pediatric hematology	34
primary outcome	34
patients aged	33
significantly associated	33
patient care	33
control group	33
platelet counts	33
significant differences	32
peripheral blood	32
clinical outcomes	32
vte events	32
five patients	32
mortality rate	31
molecular weight	31
kg day	31
heart failure	31
low risk	31
systematic review	31
patients may	31
renal function	31
new york	30
anticoagulant treatment	30
cell transplant	30
antiplatelet therapy	30
hospitalized medical	30
cancer survivors	30
risk stratification	30
computed tomography	29
stroke patients	29
solid tumors	29
creatinine clearance	29
gene expression	29
median time	29
statistical analysis	29
cumulative incidence	29
oral anticoagulants	29
young adults	29
thromboembolic complications	29
aneurysmal subarachnoid	29
thrombotic events	28
patients diagnosed	28
extended thromboprophylaxis	28
cell transplantation	28
venous thromboembolic	28
american society	28
medical history	28
study center	28
electronic medical	28
two groups	28
risk patients	28
myeloid leukemia	28
controlled trials	28
high incidence	27
iron overload	27
icu los	27
significantly lower	27
ct scan	27
data collection	27
hypercoagulable state	27
prospective cohort	27
vte rates	27
flow cytometry	27
medical record	27
patients presenting	27
patient developed	27
age years	27
mcg ml	27
white blood	27
icu admission	27
hodgkin lymphoma	26
von willebrand	26
disease severity	26
study will	26
retrospective analysis	26
plasminogen activator	26
observational study	26
may also	26
spinal cord	26
nine patients	25
pediatric population	25
nk cells	25
acute myeloid	25
enoxaparin mg	25
patients underwent	25
clinical data	25
hematology oncology	25
clinical features	25
per patient	25
dose anticoagulation	25
lower extremity	25
care units	25
ill icu	25
renal failure	25
acute chest	25
poor outcomes	24
prospective study	24
days post	24
case reports	24
guidelines recommend	24
enoxaparin sodium	24
marrow failure	24
controlled trial	24
included patients	24
refractory status	24
mg daily	24
severe novel	24
chest syndrome	24
primary efficacy	24
mental status	24
pharmacologic prophylaxis	24
kidney injury	24
direct oral	24
international society	24
prothrombin time	24
prospective studies	23
based guidelines	23
ill covid	23
clinical deterioration	23
clinical suspicion	23
retrospectively reviewed	23
twice daily	23
identified patients	23
limited data	23
high prevalence	23
good outcome	23
long term	23
per day	23
high dose	23
medical illness	23
first hours	23
american college	23
acute brain	23
prediction score	22
soft tissue	22
commonly used	22
severe coronavirus	22
mm hg	22
abnormal coagulation	22
padua prediction	22
data suggest	22
one year	22
world health	22
iu kg	22
health organization	22
glasgow coma	22
midline shift	22
every hours	22
severe disease	22
fibrinogen levels	22
confidence interval	22
neutrophil extracellular	22
previously reported	22
endothelial cells	22
patients developed	22
median follow	22
sah patients	22
low molecular	22
oral anticoagulant	22
cell proliferation	22
assessment model	22
patient outcomes	22
practice guidelines	22
higher incidence	21
ill hospitalized	21
disease patients	21
fibrinolysis shutdown	21
acute kidney	21
significantly increased	21
patients infected	21
improve outcomes	21
determine whether	21
cardiovascular disease	21
reduced mobility	21
deep venous	21
hypertonic saline	21
young adult	21
modified rankin	21
icu stay	21
predictive value	21
lopinavir ritonavir	21
patients requiring	21
white matter	21
exome sequencing	21
hemolytic anemia	21
cell count	21
partial thromboplastin	21
exclusion criteria	20
septic shock	20
consecutive patients	20
among hospitalized	20
decreased mortality	20
thromboembolic disease	20
wilms tumor	20
blood cells	20
day mortality	20
nervous system	20
analyzed using	20
acute medical	20
hearing loss	20
metastatic disease	20
extracellular traps	20
prophylactic anticoagulation	20
brain tumors	20
neutrophil count	20
may benefit	20
descriptive statistics	20
mortality rates	20
many patients	20
temperature management	20
less likely	20
family history	20
external ventricular	20
regression analysis	20
care patients	20
supportive care	19
central nervous	19
thromboplastin time	19
induced coagulopathy	19
accepted article	19
organ failure	19
viral infection	19
antiphospholipid antibodies	19
cancer patients	19
activated partial	19
surgical resection	19
three months	19
high grade	19
hours post	19
ich patients	19
functional outcome	19
discharged home	19
pilot study	19
radiation therapy	19
study population	19
randomized trials	19
vascular malformations	19
old man	19
old woman	19
induction therapy	19
heart rate	19
case highlights	19
drug interactions	19
older age	18
present study	18
hospital medical	18
vod sos	18
family members	18
factors associated	18
patients experienced	18
pet ct	18
palliative care	18
patients will	18
thromboembolism prophylaxis	18
randomized clinical	18
induced thrombocytopenia	18
coma scale	18
data regarding	18
primary care	18
cerebral perfusion	18
time points	18
clinically relevant	18
hematoma expansion	18
central venous	18
adverse effects	18
thrombolytic therapy	18
study drug	18
body mass	18
arterial thromboembolic	18
associated coagulopathy	18
well tolerated	18
tissue factor	18
tissue plasminogen	18
whole exome	18
interim guidance	18
eight patients	17
enrolled patients	17
analysis revealed	17
first case	17
dimer level	17
patients included	17
interquartile range	17
calculated using	17
pediatric patient	17
inflammatory response	17
ewing sarcoma	17
cancer diagnosis	17
efficacy outcome	17
single center	17
mass index	17
seven patients	17
proximal dvt	17
risk score	17
survival rates	17
weight loss	17
tbi patients	17
oral anticoagulation	17
host disease	17
evd placement	17
basal ganglia	17
cytokine storm	17
findings suggest	17
medical treatment	17
literature review	17
physical examination	17
obese patients	17
task force	17
statistical significance	17
six patients	17
immune function	17
pe patients	17
fold higher	16
patient presented	16
independently associated	16
clinically significant	16
hemodynamic instability	16
sectional study	16
clinical presentation	16
months post	16
patient characteristics	16
symptom onset	16
high mortality	16
patient received	16
mri brain	16
academic medical	16
performed using	16
residual disease	16
rankin scale	16
replacement therapy	16
may provide	16
lymph node	16
significantly elevated	16
subdural hematoma	16
fibrinolytic therapy	16
health outcomes	16
cerebral blood	16
central line	16
new onset	16
blood transfusion	16
exact test	16
analysis showed	16
thrombotic microangiopathy	16
medical management	16
free survival	16
reactive protein	16
blood count	15
transcranial doppler	15
identify patients	15
patients required	15
successfully treated	15
risk neuroblastoma	15
average age	15
cancer therapy	15
single institution	15
year period	15
patients enrolled	15
potential therapeutic	15
aged years	15
eligible patients	15
functional outcomes	15
spot sign	15
cns tumors	15
induction chemotherapy	15
expert panel	15
xa activity	15
severe sars	15
blood glucose	15
significant increase	15
genetic testing	15
side effect	15
parenteral anticoagulation	15
clinical management	15
recent studies	15
late effects	15
related complications	15
hospital day	15
continuous infusion	15
magnetic resonance	15
complete blood	15
diabetes mellitus	15
laboratory values	15
pain crisis	15
oncology group	15
remains unclear	15
study design	15
ct scans	15
delayed cerebral	15
lmwh prophylaxis	15
primary endpoint	15
hsct patients	15
dual antiplatelet	15
scd patients	15
acute coronary	15
six months	15
one week	15
public health	15
pharmacological thromboprophylaxis	15
healthy volunteers	15
severe hemophilia	15
clinical guidance	15
prophylactic doses	15
treatment options	15
invasive procedures	15
ich score	15
infected patients	14
bereaved parents	14
high rates	14
severe thrombocytopenia	14
screening tool	14
standardization committee	14
study aims	14
two cases	14
significantly different	14
coronary syndrome	14
absolute neutrophil	14
patients met	14
complete remission	14
chest pain	14
standard dose	14
anticoagulant prophylaxis	14
red cell	14
past medical	14
platelet aggregation	14
burst suppression	14
marrow transplantation	14
spontaneous ich	14
multivariate analysis	14
high levels	14
days following	14
results suggest	14
generation sequencing	14
elevated icp	14
tcd screening	14
severe tbi	14
mechanically ventilated	14
ambulatory patients	14
recombinant factor	14
secondary outcomes	14
cerebral ischemia	14
lymph nodes	14
mcar antibodies	14
ventricular drain	14
lactate dehydrogenase	14
clinical outcome	14
isth interim	14
cognitive impairment	14
hospital visit	14
liver biopsy	14
vital signs	14
leading cause	14
serum creatinine	14
higher rates	14
primary objective	14
adherence rates	14
high rate	14
days later	14
interim analysis	14
willebrand factor	14
may help	13
standard deviation	13
blood culture	13
panel report	13
oxygen saturation	13
coagulation activation	13
chest guideline	13
two years	13
vte among	13
hospital course	13
endothelial injury	13
lupus anticoagulant	13
mg twice	13
developed vte	13
rare case	13
european society	13
laboratory findings	13
monoclonal antibody	13
pulmonary thrombosis	13
two months	13
maintenance therapy	13
ds aml	13
worse outcomes	13
randomized trial	13
physical therapy	13
common cause	13
cd cells	13
renal replacement	13
linear regression	13
patients showed	13
general population	13
mass effect	13
may occur	13
cerebral artery	13
copy number	13
higher rate	13
platelet function	13
year post	13
significant reduction	13
anoxic brain	13
abdominal pain	13
upper limit	13
among children	13
initial presentation	13
month period	13
future research	13
pe group	13
viral infections	13
significant risk	13
irb approval	13
endothelial dysfunction	13
tyrosine kinase	13
tumor cells	13
better understand	13
significantly reduced	13
normal range	13
hospital length	13
severe anemia	13
solid tumor	13
without covid	13
iv antibiotics	13
laboratory data	13
blood samples	13
immune system	13
small sample	13
previously published	13
negative predictive	13
study medication	13
compared using	13
preliminary data	13
acute stroke	13
middle east	13
regression model	13
chronic transfusion	13
glasgow outcome	13
adult inpatients	13
cerebrospinal fluid	13
communication skills	13
painful stimulation	12
help guide	12
organ dysfunction	12
physical activity	12
care setting	12
globin gene	12
burkitt lymphoma	12
female presented	12
well studied	12
associated vte	12
gene mutation	12
days prior	12
multicenter prospective	12
mrna expressions	12
month follow	12
brain tumor	12
high vte	12
findings support	12
least months	12
blood coagulation	12
ich volume	12
outcomes included	12
urinary tract	12
graft failure	12
dose steroids	12
resonance imaging	12
important role	12
dose heparin	12
differential diagnosis	12
favorable outcome	12
treatment modalities	12
odds ratio	12
study also	12
padua score	12
cardiac injury	12
injured patients	12
heart disease	12
two weeks	12
patient underwent	12
hospital los	12
altered mental	12
ward patients	12
previously described	12
cd cd	12
febrile neutropenia	12
clinical response	12
thromboembolism risk	12
lower limb	12
significant morbidity	12
large vessel	12
healthy subjects	12
severe traumatic	12
cd count	12
clinical benefit	12
practical guidance	12
brain mri	12
medical college	12
previously healthy	12
brain edema	12
univariate analysis	12
increased prevalence	12
major cause	12
one month	12
intraventricular hemorrhage	12
data suggests	12
patients using	12
vte incidence	12
packed red	12
stroke prevention	12
within one	12
temporal lobe	12
among pediatric	12
positive patients	12
infectious disease	12
continuous eeg	12
multivariable logistic	12
respiratory infection	12
coagulation cascade	12
may lead	12
acute infection	12
eeg patterns	12
disease progression	12
acute phase	12
internal medicine	12
care team	12
improve patient	12
term follow	12
pain scores	12
organ donation	12
may result	12
acute vte	12
serious adverse	12
imaging findings	12
primary diagnosis	12
inflammatory cytokines	12
met inclusion	12
pulmonary hypertension	12
within months	12
pain control	12
autopsy findings	11
lower risk	11
prospective observational	11
factor ix	11
stroke center	11
several days	11
stem cells	11
may present	11
clot formation	11
elderly patients	11
general ward	11
one case	11
marrow transplant	11
outcome measures	11
extremely rare	11
acute pe	11
hematology guidelines	11
trend towards	11
membrane oxygenation	11
remaining patients	11
clinical improvement	11
acute neurological	11
ochsner health	11
immune dysfunction	11
previous studies	11
bleeding episodes	11
year os	11
also found	11
east respiratory	11
imaging showed	11
developed acute	11
venous catheters	11
consensus statement	11
increased mortality	11
study aimed	11
cxr findings	11
prophylactic dose	11
age groups	11
bacterial infection	11
published data	11
partial response	11
data collected	11
pao fio	11
left ventricular	11
autosomal recessive	11
physical exam	11
ethics committee	11
repeat imaging	11
mean arterial	11
immune response	11
objectively confirmed	11
year overall	11
carotid artery	11
aml patients	11
extended prophylaxis	11
received iv	11
renal dysfunction	11
medical care	11
american heart	11
ct angiography	11
three days	11
ngt peg	11
patients reported	11
lymphocyte ratio	11
tgf beta	11
ct showed	11
heart association	11
may require	11
ten patients	11
may represent	11
postdischarge vte	11
endovascular treatment	11
blood counts	11
covid patients	11
male presented	11
bleeding disorder	11
body temperature	11
adverse event	11
ovid study	11
marrow biopsy	11
unrelated donor	11
clinical variables	11
multivariable analysis	11
cell death	11
brain tissue	11
external validation	11
marrow evaluation	11
increased incidence	11
systemic inflammation	11
electrographic seizures	11
high index	11
center retrospective	11
team members	11
receiver operating	11
outcome scale	11
university hospital	11
old caucasian	11
mri showed	11
safety profile	11
three times	11
vte prevention	11
target cells	11
will receive	11
internal carotid	11
baseline characteristics	11
infectious complications	11
bypass surgery	11
year survival	11
chain reaction	11
cerebral venous	11
small molecule	11
neuro icu	11
pharmacologic vte	11
renal clearance	11
elevation myocardial	10
vte disease	10
prospectively collected	10
coagulation factors	10
patients years	10
gene ontology	10
routine use	10
hazard ratio	10
take place	10
highest risk	10
intracranial hypertension	10
dose lmwh	10
resource utilization	10
real time	10
rank sum	10
arterial pressure	10
next generation	10
vasogenic edema	10
fxa activity	10
bleeding events	10
wilcoxon rank	10
measured using	10
high frequency	10
times per	10
intensive chemotherapy	10
cell acute	10
previous vte	10
glioblastoma multiforme	10
mean difference	10
retrospectively analyzed	10
treatment related	10
respiratory rate	10
splenic sequestration	10
anticoagulation therapy	10
pulmonary vascular	10
teaching hospital	10
tcd velocities	10
minimal residual	10
ambulatory treatment	10
reported case	10
converting enzyme	10
data analysis	10
leptomeningeal enhancement	10
low dose	10
severe ncp	10
stage iv	10
observational studies	10
graft versus	10
tumor growth	10
testing revealed	10
specific gravity	10
well described	10
central lines	10
therapy may	10
viral pneumonia	10
venous access	10
response rate	10
significant association	10
pg ml	10
improve score	10
subgroup analysis	10
treated patients	10
extracorporeal membrane	10
serum ferritin	10
hemoglobin electrophoresis	10
clinical information	10
extremely high	10
hydroxyurea use	10
subcutaneously every	10
well documented	10
close monitoring	10
mononuclear cells	10
pdsa cycles	10
without dvt	10
fxa levels	10
versus host	10
marrow aspirate	10
exchange transfusion	10
median survival	10
qi intervention	10
may improve	10
lumbar puncture	10
patient days	10
clearance ml	10
additional information	10
guidance statements	10
neurointensive care	10
scoring system	10
current guidelines	10
primary stroke	10
independent predictors	10
cell immunity	10
patients whose	10
liquid hu	10
patients within	10
future studies	10
academic hospital	10
three groups	10
treatment failure	10
prothrombotic state	10
stage iii	10
significantly decreased	10
health literacy	10
studies suggest	10
day survival	10
health record	10
developmental delay	10
pediatric aml	10
respiratory symptoms	10
antiviral agents	10
igf levels	10
ct head	10
behavioral adherence	10
liver enzymes	10
significant decrease	10
patient demographics	10
first line	10
arterial verapamil	10
first year	10
hyperosmolar therapy	10
degradation products	10
occlusive crisis	10
renal disease	10
critical illness	10
median gcs	10
higher doses	10
laboratory test	10
data available	10
young children	10
life support	10
included studies	10
relevant bleeding	10
polymerase chain	10
care workers	9
months later	9
based dosing	9
electronic health	9
atypical hus	9
studies reporting	9
clinical condition	9
outpatient setting	9
cell lymphoma	9
bleeding symptoms	9
deletion duplication	9
term outcomes	9
cell line	9
old girl	9
aml cells	9
cause death	9
synovial sarcoma	9
routine screening	9
operating characteristic	9
hydroxyurea therapy	9
nonhospitalized medical	9
study sought	9
tertiary care	9
assessment tool	9
cluster randomized	9
hours prior	9
nursing staff	9
single dose	9
coagulation abnormalities	9
developing vte	9
hemorrhagic stroke	9
icu hospitalized	9
higher mortality	9
per week	9
mean duration	9
single agent	9
five days	9
steady state	9
arterial thrombosis	9
life care	9
fellowship programs	9
mechanical prophylaxis	9
breakthrough cinv	9
optic nerve	9
artery disease	9
mapk pathway	9
antiphospholipid syndrome	9
surgical intervention	9
vte rate	9
unique case	9
inflammatory state	9
progressive disease	9
acute intracranial	9
vast majority	9
even higher	9
mechanical thrombectomy	9
mri revealed	9
brain showed	9
cc kg	9
associated complications	9
older patients	9
patients achieved	9
ultrasound screening	9
receiving chemotherapy	9
may include	9
metastatic wt	9
receiving prophylactic	9
systemic anticoagulation	9
increasingly used	9
asah patients	9
refractory se	9
ct angiogram	9
periodic discharges	9
ventilated patients	9
cell anemia	9
severe renal	9
coronary artery	9
induced anti	9
limb ischemia	9
cardiovascular events	9
anticoagulated severe	9
total number	9
eligibility criteria	9
prior vte	9
posterior circulation	9
gold standard	9
african american	9
somatic mutations	9
cardiac dysfunction	9
body weight	9
cl care	9
thrombosis prophylaxis	9
younger age	9
thrombin generation	9
similar results	9
mg day	9
without pe	9
accompanying person	9
immediate post	9
low levels	9
strongly associated	9
criteria included	9
birth weight	9
targeted therapies	9
right heart	9
among covid	9
also reported	9
care society	9
nonhospitalized patients	9
improved outcomes	9
cancer treatment	9
categorical variables	9
thromboembolic risk	9
responded well	9
potential benefits	9
cm sec	9
ejection fraction	9
hematologic malignancies	9
thalassemia trait	9
acute care	9
life threatening	9
disease burden	9
requiring hospitalization	9
bad news	9
lower mortality	9
positive blood	9
vs without	9
pediatric cancers	9
endotracheal intubation	9
pulmonary function	9
intraparenchymal hemorrhage	9
acute limb	9
pediatric intensive	9
middle cerebral	9
gestational age	9
clinical care	9
barr virus	9
chronic gvhd	9
renal insufficiency	9
hydroxyurea treatment	9
significantly improved	9
appropriate prophylaxis	9
serum sodium	9
medical illnesses	9
antibiotic therapy	9
metastatic potential	9
optimal management	9
significant bleeding	9
severe pneumonia	9
pk parameters	9
asymptomatic dvt	9
imaging studies	9
autoimmune hemolytic	9
study included	9
brain injuries	9
clinical significance	9
hematoma volume	9
systolic blood	9
elevated levels	9
vte diagnosis	9
cd car	9
western blot	9
laboratory parameters	9
intravenous immunoglobulin	9
neutrophil engraftment	8
potential confounders	8
diagnostic testing	8
family engagement	8
blood loss	8
significantly greater	8
mirage syndrome	8
done using	8
sided weakness	8
willebrand disease	8
cell therapy	8
medical staff	8
diffuse alveolar	8
descriptive study	8
demographic data	8
cell cycle	8
elevated intracranial	8
respiratory disease	8
several studies	8
multivariate logistic	8
bleeding disorders	8
targeted temperature	8
endothelial cell	8
block group	8
extubation failure	8
pulmonary angiography	8
tomography pulmonary	8
iu ml	8
severe cases	8
onsd measurement	8
clinical conditions	8
count kg	8
study protocol	8
nerve sheath	8
study suggests	8
may impact	8
month old	8
study participation	8
care providers	8
advanced cancer	8
baseline data	8
patient data	8
heparin resistance	8
laboratory testing	8
acquired vte	8
line placement	8
within minutes	8
sinus thrombosis	8
children undergoing	8
may reflect	8
dg pl	8
flow diversion	8
reduced dose	8
cancer center	8
another study	8
coil embolization	8
following acute	8
molecule inhibitors	8
continuous variables	8
italian society	8
neuroblastoma patients	8
coronary intervention	8
neurological deficits	8
left lower	8
transcription factor	8
cause mortality	8
times daily	8
average number	8
anticoagulation treatment	8
blood transfusions	8
pupillary reactivity	8
standard doses	8
oncology fellowship	8
cha ds	8
medical prevention	8
absolute lymphocyte	8
extraneural metastases	8
cd expression	8
outcome group	8
phase i	8
younger patients	8
intermediate risk	8
high bleeding	8
multidisciplinary team	8
fecal management	8
recent data	8
regression analyses	8
tongji hospital	8
phase trial	8
well established	8
exosomal mir	8
first reported	8
unclear whether	8
positive rpp	8
encephalopathy syndrome	8
patient selection	8
patients presented	8
acute severe	8
previous study	8
clinical signs	8
advanced age	8
patient populations	8
clinical setting	8
apache ii	8
cranial nerve	8
year efs	8
vascular anomalies	8
augmented renal	8
acute renal	8
icp mmhg	8
poorly understood	8
anesthetic agents	8
deemed necessary	8
anticoagulation forum	8
duplication analysis	8
prognostic factors	8
cytokine release	8
patient safety	8
cohort studies	8
culture episodes	8
enteral antihypertensive	8
received mg	8
may increase	8
peripheral smear	8
comfort care	8
outside hospital	8
adverse effect	8
treating physician	8
acute leukemia	8
intensity anticoagulation	8
study group	8
alveolar damage	8
undergoing hsct	8
transfer patients	8
tested positive	8
acute management	8
pulmonary disease	8
comatose patients	8
low bmd	8
tier ii	8
related mortality	8
studies showed	8
confirmed vte	8
combination therapy	8
executive functioning	8
patients died	8
voc days	8
received anticoagulation	8
secondary objectives	8
biopsy showed	8
respiratory support	8
icu pts	8
prevent vte	8
best practices	8
clinical study	8
sc injection	8
disease course	8
improvement project	8
associated acute	8
seven days	8
tract hemorrhages	8
organ transplantation	8
medical inpatients	8
position paper	8
treatment strategies	8
expert consensus	8
early post	8
beta thalassemia	8
conventional chemotherapy	8
study demonstrated	8
showed diffuse	8
literature search	8
lymphocyte count	8
significant impact	8
will help	8
showed significant	8
cancer institute	8
braf fusion	8
gata mutation	8
current literature	8
liver function	8
grade gliomas	8
potential risk	8
icu needs	8
recent study	8
plasma igf	8
hospital complications	8
blood smear	8
death within	8
iic patterns	8
complete resolution	8
research hospital	8
heparin prophylaxis	8
will take	8
nasal cannula	8
ischemic strokes	8
international medical	8
prior history	8
suspected vte	8
time period	8
pdsa cycle	8
platelet transfusions	8
within weeks	8
available data	8
professional development	8
nk cell	8
platelet activation	8
apnea test	8
significant changes	8
early detection	8
care ultrasound	8
peer review	8
line therapy	8
common complication	8
current evidence	8
arterial blood	8
immune reconstitution	8
school reentry	8
mrna expression	8
surgical decompression	8
complications including	8
mcg kg	8
doppler ultrasound	8
ards patients	8
will need	8
tube placement	8
clinical decision	8
northern italy	8
significant improvement	8
agents used	8
stable disease	8
age group	8
baylor college	8
cell mediated	8
spine surgery	8
family medicine	8
mean time	8
may wish	8
xa level	8
analysis will	8
primary pci	8
active bleeding	8
lymphoblastic lymphoma	8
risk assessments	8
social network	8
brain herniation	8
cytokine production	8
reticulocyte count	8
ill patient	8
least days	8
widely accepted	8
hepatic hemangiomas	8
head injury	8
working memory	8
transfer time	8
early use	8
workup revealed	8
treatment protocols	8
also significantly	8
bleeding complications	8
systemic therapy	8
conducted using	8
study treatment	8
ddavp administration	8
protective effect	7
medical education	7
pupil size	7
kg subcutaneously	7
therapeutic interventions	7
socioeconomic status	7
pediatric acute	7
clinicians may	7
epileptiform discharges	7
subgroup analyses	7
right ventricular	7
future directions	7
cd ra	7
iron deficiency	7
thalassemia patients	7
next day	7
adverse outcomes	7
patients discharged	7
one study	7
lymphocyte counts	7
cxcr cxcr	7
collected data	7
bleeding phenotype	7
compression ultrasonography	7
closely related	7
stroke centers	7
lv dysfunction	7
daily dose	7
radiographic evidence	7
mechanical thromboprophylaxis	7
reference range	7
neurostimulant medications	7
cell surface	7
mild thrombocytopenia	7
treatment group	7
fellowship program	7
tract infections	7
mri demonstrated	7
repeated sc	7
versus placebo	7
systemic symptoms	7
higher dose	7
subsequently developed	7
systolic bp	7
acute infections	7
complication rates	7
patients survived	7
heart strain	7
stroke risk	7
retrospective observational	7
pediatric residents	7
maximum amplitude	7
previous months	7
neurological outcomes	7
immune cells	7
higher mean	7
refractory agvhd	7
emergency departments	7
scientific evidence	7
syndrome patients	7
week history	7
also known	7
evaluated using	7
patient continued	7
group poverty	7
factor xa	7
received therapeutic	7
functional hemoglobin	7
medenox study	7
post hoc	7
commonly seen	7
matched unrelated	7
two days	7
hemodynamically stable	7
surface area	7
epic tm	7
kidney disease	7
clamp trial	7
associated pneumonia	7
first weeks	7
time window	7
rare disease	7
neurosciences intensive	7
cell histiocytosis	7
medulloblastoma cells	7
control study	7
estimated day	7
recent laboratory	7
assessment models	7
healthcare workers	7
hospital survival	7
pulmonary emboli	7
thalassemia major	7
diagnostic criteria	7
direct co	7
adhesion molecules	7
international guidelines	7
early clamp	7
negative mrd	7
contraindication exists	7
initial treatment	7
incidence rates	7
leukemia cells	7
vessel wall	7
markedly elevated	7
infectious diseases	7
hd deferoxamine	7
case describes	7
young patients	7
treatment option	7
autoimmune disease	7
urine specific	7
per year	7
severe illness	7
nonacog alfa	7
may offer	7
posterior reversible	7
mtx levels	7
patient required	7
urgent need	7
ocular ultrasound	7
claims data	7
data support	7
pulmonary opacity	7
global health	7
one died	7
medical team	7
patient family	7
including acute	7
clinical question	7
regression models	7
continuous renal	7
hepatocellular carcinoma	7
prbc transfusions	7
stroke symptoms	7
data points	7
opportunistic infections	7
transfusional iron	7
aneurysmal sah	7
fda approved	7
current standard	7
vte bundle	7
severely ill	7
income countries	7
stroke care	7
data will	7
retrospective case	7
clinical predictors	7
test results	7
nurse practitioners	7
cord injury	7
significant proportion	7
approximately one	7
consent form	7
conditioning regimen	7
tumor necrosis	7
vaccine series	7
prophylactic treatment	7
sodium levels	7
interval ci	7
electronic monitoring	7
prophylaxis rate	7
interim clinical	7
wound infections	7
empiric therapeutic	7
patients following	7
using descriptive	7
diagnosis codes	7
amyloid angiopathy	7
thromboelastography findings	7
dose anticoagulant	7
trauma patients	7
mrd negative	7
heavy menstrual	7
cyclic neutropenia	7
nationally representative	7
median duration	7
perihematomal edema	7
antimicrobial therapy	7
lmwh may	7
correlation coefficient	7
medical centers	7
initial parenteral	7
post injury	7
extremity deep	7
subcortical myoclonus	7
transfusion therapy	7
patient demonstrated	7
common finding	7
patients taking	7
johns hopkins	7
despite aggressive	7
first study	7
identified studies	7
years vs	7
global cerebral	7
institutional protocols	7
significantly correlated	7
large academic	7
training program	7
previous research	7
comprehensive stroke	7
dose enoxaparin	7
also associated	7
one third	7
primary outcomes	7
day course	7
improve survival	7
admitted patients	7
first report	7
dedicated neurocritical	7
hyperexcitable patterns	7
event rate	7
intracranial aneurysms	7
apnea testing	7
cerebral autoregulation	7
despite treatment	7
therapeutic target	7
outcomes associated	7
key role	7
clot strength	7
develop vte	7
flow nasal	7
pain score	7
left frontal	7
neurological injury	7
may serve	7
potential treatment	7
likely due	7
surgical patients	7
underwent hsct	7
similar cases	7
medical therapy	7
intravenous ufh	7
troponin levels	7
source data	7
will provide	7
total sample	7
normal platelet	7
intracranial hypotension	7
early studies	7
inhospital mortality	7
clinical exam	7
hemolytic uremic	7
assessed using	7
pulmonary artery	7
treatment approaches	7
higher prevalence	7
cerebral vasospasm	7
group allocation	7
uremic syndrome	7
successful treatment	7
vessel occlusion	7
excluded patients	7
inflammatory effects	7
randomization will	7
takotsubo cardiomyopathy	7
survival among	7
nonsurgical patients	7
cell products	7
hemophagocytic lymphohistiocytosis	7
following treatment	7
major thromboembolic	7
neuromuscular blockade	7
thrombotic risk	7
cerebral infarction	7
novel therapeutic	7
without significant	7
mortality among	7
medulloblastoma cell	7
united kingdom	7
filled syringes	7
even though	7
acute gvhd	7
mg subcutaneously	7
frontal lobe	7
clinical questions	7
male patients	7
trauma center	7
survival rate	7
clopidogrel ticagrelor	7
myocardial fibrosis	7
evaluated patients	7
will also	7
jugular bulb	7
allogeneic hematopoietic	7
quality assurance	7
aha acc	7
longer duration	7
xa levels	7
occurring within	7
spontaneous intracerebral	7
chemotherapy regimens	7
healthcare providers	7
ischemic brain	7
york city	7
prevention registry	7
discharged alive	7
pooled analysis	7
icp monitoring	7
icu length	7
bleeding diathesis	7
safety events	7
patient satisfaction	7
inpatient sample	7
acute myocardial	7
clot lysis	7
authors declare	7
organ damage	7
five cases	7
percutaneous coronary	7
selection bias	7
iv brv	7
final analysis	7
diffuse myocardial	7
penn state	7
analysis demonstrated	7
prior ich	7
peking union	7
processing speed	7
active cancer	7
using spss	7
cultures drawn	7
anterior circulation	7
macrocytic anemia	7
health systems	7
identified using	7
adjunctive therapy	7
three years	7
andexanet bolus	7
standard hygiene	7
reversible encephalopathy	7
vte despite	7
immunocompromised patients	7
will include	7
first days	7
union medical	7
burr hole	7
risk profile	6
small number	6
restricted diffusion	6
using standard	6
insufficient data	6
prothrombin complex	6
associated thrombosis	6
national institute	6
neutrophil counts	6
ews fli	6
portal vein	6
sheath diameter	6
reported rates	6
patients developing	6
widely used	6
frequently observed	6
review board	6
stage i	6
central role	6
results indicate	6
treatment outcomes	6
versus warfarin	6
every months	6
hospital thromboprophylaxis	6
patients exposed	6
lower extremities	6
standard treatment	6
cvc associated	6
dna methylation	6
north america	6
neutropenic patients	6
large volume	6
brainstem reflexes	6
strongly agree	6
may affect	6
rare complication	6
san matteo	6
patients receive	6
perfusion pressure	6
neurological recovery	6
journal club	6
genetic risk	6
international classification	6
data capture	6
traumatic intracranial	6
relapsed aml	6
multidisciplinary approach	6
pulmonary dysfunction	6
previous reports	6
complete response	6
shared decision	6
typically seen	6
mean ambulatory	6
identify hospitalized	6
initial head	6
vte prevalence	6
icu days	6
hours later	6
potential benefit	6
spinal fluid	6
deficiency anemia	6
ct demonstrated	6
menstrual bleeding	6
reported symptoms	6
experimental group	6
last years	6
first patients	6
limited resources	6
revealed normal	6
known complication	6
hematopoietic cell	6
trough levels	6
smear showed	6
mild covid	6
cov test	6
training programs	6
multimodal monitoring	6
hyper ige	6
intravascular coagulopathy	6
decompressive hemicraniectomy	6
using standardized	6
hemorrhagic transformation	6
left eye	6
care provider	6
standardized management	6
hospital acquired	6
national institutes	6
epileptiform activity	6
extended postdischarge	6
major ht	6
practice patterns	6
wide multifaceted	6
poverty status	6
outcome data	6
unless contraindicated	6
diffuse cerebral	6
status post	6
iron burden	6
consumptive coagulopathy	6
grade sah	6
tertiary referral	6
ages ranged	6
duration thromboprophylaxis	6
will allow	6
sofa score	6
ventriculoperitoneal shunt	6
nutritional status	6
study showed	6
patients often	6
case basis	6
first patient	6
cervical spinal	6
statistically different	6
antiplatelet agents	6
first months	6
drain placement	6
appropriate management	6
undergoing chemotherapy	6
compression stockings	6
brain revealed	6
academic tertiary	6
cov infection	6
reported cases	6
cd ratio	6
previously treated	6
empiric antibiotics	6
antihypertensive medication	6
previous year	6
risk scores	6
hygiene requirements	6
antimicrobial prophylaxis	6
outpatient vte	6
time frame	6
role play	6
visual inspection	6
diffuse astrocytoma	6
peripherally inserted	6
may contribute	6
local control	6
organ function	6
molecular mechanisms	6
lung injury	6
ecmo support	6
neurosurgical intervention	6
prophylaxis may	6
solid organ	6
hemoglobin level	6
healthcare professionals	6
disease control	6
subdural hemorrhage	6
pta duration	6
studies reported	6
pa patients	6
survivorship care	6
staff members	6
frequently asked	6
relative risk	6
desmoid tumors	6
phone call	6
study procedures	6
treatment guidelines	6
airway pressure	6
social media	6
failure rate	6
renal impairment	6
prone position	6
ct imaging	6
aspirin plus	6
cervical spine	6
diabetic ketoacidosis	6
phe expansion	6
posterior fossa	6
data elements	6
gene testing	6
patients based	6
full dose	6
bmi patients	6
mean number	6
prolonged pt	6
meningioma resection	6
laboratory tests	6
care system	6
readmission scores	6
many institutions	6
prophylaxis dosing	6
peak plasma	6
directed therapy	6
disease sites	6
acute infectious	6
cancer incidence	6
internalizing symptoms	6
hemorrhage patients	6
treatment plan	6
sc administration	6
mean length	6
study personnel	6
provide guidance	6
provide additional	6
chelation therapy	6
study cohort	6
including uedvt	6
group patients	6
neurologic deterioration	6
sofa scores	6
coronavirus infection	6
patients despite	6
often used	6
femoral vein	6
post hsct	6
activator inhibitor	6
primary aim	6
clinical research	6
investigator will	6
mediated immunity	6
metastatic osteosarcoma	6
amino acid	6
west nile	6
hu adherence	6
increased icp	6
initial therapy	6
release syndrome	6
ensoetm recipients	6
median days	6
larger prospective	6
good vs	6
monitored closely	6
intermittent pneumatic	6
documented vte	6
caucasian male	6
coma score	6
major clinically	6
layer mscs	6
infected pneumonia	6
diffusion restriction	6
showed improvement	6
acute sci	6
institutional protocol	6
upper extremity	6
red cells	6
vascular thrombosis	6
fibrin polymerization	6
clinically suspected	6
preferred agent	6
random effects	6
blood product	6
neuroscience icu	6
requiring mechanical	6
prior reports	6
procoagulant pattern	6
gi agvhd	6
evd insertion	6
within years	6
children diagnosed	6
commercially available	6
two cycles	6
treatment decisions	6
coagulation system	6
blood pressures	6
twenty patients	6
required mechanical	6
patient age	6
steroid therapy	6
collected included	6
existing guidelines	6
treatment dose	6
well defined	6
treatment duration	6
confirmed covid	6
icu setting	6
ige syndrome	6
transfused group	6
amongst patients	6
severe profound	6
related adverse	6
cerebral oxygen	6
disease free	6
sympathetic storming	6
seventeen patients	6
hospitals will	6
chemotherapy treatment	6
study participants	6
pediatric hsct	6
sodium chloride	6
therapy completion	6
associative models	6
prone diabetes	6
additional patients	6
diffuse midline	6
proinflammatory cytokines	6
additional risk	6
brainstem hemorrhage	6
standard risk	6
pneumonia incidence	6
blood stream	6
patients also	6
inpatient rehabilitation	6
medication adherence	6
platelet response	6
petrous ica	6
incidence rate	6
medical conditions	6
kinase inhibitor	6
cancer hospital	6
copyright holder	6
gad ab	6
chemotherapy alone	6
clinical status	6
asked questions	6
care practices	6
may prevent	6
consumption coagulopathy	6
lung disease	6
study evaluated	6
laboratory evaluation	6
blood test	6
cell recovery	6
antiepileptic drugs	6
enroll patients	6
inserted central	6
emotional distress	6
may reduce	6
median dose	6
year follow	6
following spine	6
autosomal dominant	6
evidence suggests	6
last dose	6
association task	6
septic patients	6
cov testing	6
craniospinal radiation	6
sum test	6
stroke severity	6
old boy	6
malignant cerebral	6
sickle trait	6
patients venous	6
pharmacological prophylaxis	6
decision support	6
initial diagnosis	6
primary diagnoses	6
angiogram showed	6
imaging revealed	6
likert scale	6
oxygen delivery	6
study outcomes	6
clinical scenarios	6
diabetes insipidus	6
care population	6
organ procurement	6
pneumatic compression	6
time spent	6
genetic analysis	6
following cardiac	6
relapsed patients	6
enoxaparin will	6
left sided	6
medical ward	6
disease may	6
trial design	6
moderate risk	6
comfort level	6
surgical splenectomy	6
improved significantly	6
low threshold	6
voc events	6
may need	6
days vs	6
code status	6
poor prognostic	6
atypical hemolytic	6
artery occlusion	6
diagnosed patients	6
catheter associated	6
pediatric pwh	6
bleeding scores	6
cost savings	6
past months	6
march th	6
receive anticoagulation	6
promising results	6
ketosis prone	6
reference ranges	6
symptomatic venous	6
scale score	6
data exists	6
multimodal therapy	6
times higher	6
cell adhesion	6
minimal side	6
severe respiratory	6
profound hearing	6
management protocols	6
low fibrinogen	6
platelet transfusion	6
mibg scan	6
functional connectivity	6
recurrent vte	6
less common	6
also showed	6
fibrin deposition	6
multimodality monitoring	6
committee communication	6
high morbidity	6
cox proportional	6
post discharge	6
severe hypercoagulability	6
proton therapy	6
despite standard	6
sudden onset	6
piv placement	6
events occurring	6
met criteria	6
tissue oxygenation	6
early recognition	6
study pulmonary	6
correlation coefficients	6
institutional review	6
standard thromboprophylaxis	6
successful recanalization	6
index clones	6
adverse drug	6
timely diagnosis	6
demonstrated high	6
severe enough	6
topical sirolimus	6
inflammatory markers	6
clinical studies	6
electronic data	6
good neurological	6
received heparin	6
data showed	6
study using	6
second line	6
thromboprophylaxis strategies	6
trend toward	6
severe neutropenia	6
targeted therapy	6
sleep apnea	6
risk population	6
clinical manifestations	6
cell transfusions	6
negative cultures	6
hypoxic ischemic	6
secondary brain	6
healthy donors	6
oncology providers	6
hunt hess	6
lower lobe	6
prominent changes	6
eeg monitoring	6
treatment course	6
oxidative stress	6
liver dysfunction	6
higher initial	6
chest guidelines	6
independent predictor	6
currently available	6
retrospective data	6
commercial insurance	6
therapeutic doses	6
serotonin syndrome	6
kansas city	6
diastolic dysfunction	6
versatile heparin	6
ganglia ich	6
ambulatory clabsi	6
relapsed disease	6
care settings	6
complex concentrate	6
dose methotrexate	6
jak stat	6
autonomic instability	6
china clinical	6
outcome measure	6
early tracheostomy	6
despite receiving	6
metabolic acidosis	6
alfa group	6
vs poor	6
inpatient hospice	6
positive predictive	5
without mod	5
viscoelastic testing	5
five year	5
liver iron	5
eeg reactivity	5
well understood	5
matteo hospital	5
onset seizures	5
admission diagnosis	5
advanced practice	5
patients demonstrated	5
artery aneurysm	5
neurology residents	5
cell membrane	5
thrombosis among	5
multicenter cluster	5
significantly delayed	5
care within	5
threatening complications	5
confirmed diagnosis	5
hispanic patients	5
cognitive reserve	5
staff exposure	5
cancer centers	5
gastrostomy tube	5
guideline panel	5
functional status	5
cancer registry	5
unfavorable outcome	5
higher scores	5
management protocol	5
significant interaction	5
ric hsct	5
clinical evidence	5
uric acid	5
will assess	5
normalized ratio	5
intrauterine transfusions	5
diagnostic workup	5
pcc administration	5
treating physicians	5
investigators will	5
cerebral herniation	5
last patient	5
national cancer	5
well known	5
university hospitals	5
sequencing revealed	5
esc guidelines	5
direct evidence	5
cure rates	5
sic score	5
portal hypertension	5
procurement organization	5
mean pretransfusion	5
marrow disease	5
recognized complication	5
isogenic sds	5
initial evaluation	5
healthy controls	5
patient experienced	5
folate supplementation	5
initially presented	5
seizure activity	5
dose ara	5
another hospital	5
diffuse leptomeningeal	5
mobile technology	5
statistical analyses	5
grade i	5
positive results	5
test center	5
false positive	5
salvage chemotherapy	5
medical information	5
interventional radiology	5
comorbidity index	5
twelve patients	5
male gender	5
hps type	5
air emboli	5
per cog	5
kg wk	5
coagulation features	5
small case	5
identify potential	5
autoimmune encephalitis	5
center cohort	5
systematic assessment	5
mechanisms underlying	5
patients identified	5
thromboprophylaxis justified	5
itd use	5
treatment algorithm	5
egypt background	5
preliminary results	5
will serve	5
updated analysis	5
prolonged hospital	5
hospital protocol	5
cases reported	5
underwent right	5
secondary hlh	5
four cases	5
complicated voc	5
fatal outcomes	5
successful use	5
pneumonia induced	5
philadelphia chromosome	5
published guidelines	5
ct revealed	5
primary disease	5
race ethnicity	5
will decrease	5
discharge letters	5
patient became	5
neuroscience intensive	5
outcomes related	5
general health	5
ionic contrast	5
positive test	5
induced anemia	5
small bowel	5
ambulatory total	5
amyloid deposition	5
relapsed refractory	5
surgical interventions	5
initial gcs	5
psychosocial assessment	5
using icd	5
developed chronic	5
medical condition	5
pediatric hl	5
also developed	5
rankin score	5
symptomatic patients	5
dimer values	5
assess whether	5
died due	5
emergency room	5
patient outcome	5
reversal guideline	5
least weeks	5
extremity dvt	5
requiring intubation	5
aneurysm instability	5
pediatric scd	5
tube feeding	5
especially high	5
good outcomes	5
cardiac catheterization	5
aplastic anemia	5
soluble il	5
complications related	5
severe bleeding	5
cytotoxicity assay	5
thyroid cancer	5
cell viability	5
aortic valve	5
factors affecting	5
receptor complex	5
patients extended	5
plasma osmolality	5
diastolic function	5
strong predictor	5
improve vte	5
common bleeding	5
anemia due	5
surviving patients	5
starting chemotherapy	5
line therapies	5
optimal cut	5
ceegm headset	5
port placement	5
increased likelihood	5
spontaneous resolution	5
cardiovascular considerations	5
medical outpatients	5
thromb haemost	5
mitis oralis	5
broad spectrum	5
blood work	5
chemotherapeutic agents	5
prediction models	5
lab values	5
expression analysis	5
index clone	5
aggregation testing	5
new orleans	5
medical patient	5
diastolic bp	5
shrna tm	5
gp bacteremia	5
temptraq patch	5
venous blood	5
continuous electroencephalography	5
cost per	5
adjusted mean	5
acc aha	5
secondary endpoints	5
vertebral lesions	5
longer icu	5
high quality	5
hours despite	5
patients completed	5
clinical symptoms	5
plasma anti	5
chronic management	5
aha guideline	5